SmartCT R3.0 is subject to regulatory clearance and may not be available in all markets. Contact your sales representative for more details.
*The user level of expertise required is described is the Instructions for Use as the Intended Operator Profile.
**Evaluated with clinical users in a simulated lab environment with a total of 17 teams consisting of a physician and a radio-tech with different levels of experience.
***It is the operator’s responsibility to select the appropriate contrast agent depending on the clinical application. For more information about the indications for use of the contrast agent, refer to the instructions for use of the applicable contrast agent.
****3D reconstructions at higher resolution settings may take longer times.
1. Schernthaner et al., Feasibility of a Modified Cone-Beam CT Rotation Trajectory to Improve Liver Periphery Visualization during Transarterial Chemoembolization, Radiology, 2015carcinoma: comparison with intravenous contrast-enhanced, biphasic, dynamic MDCT. European Radiology. 22(4):872-9. DOI: 10.1007/s00330-011-2324-y
2. Higashihara, H., Osuga, K., Onishi, H., Nakamoto, A., Tsuboyama, T., Maeda, N., … Tomiyama, N. (2012). Diagnostic accuracy of C-arm CT during selective transcatheter angiography for hepatocellular carcinoma: comparison with intravenous contrast-enhanced, biphasic, dynamic MDCT. European Radiology. 22(4):872-9. DOI: 10.1007/s00330-011-2324-y.
3. Loffroy, R., Lin, M., Rao, P., Bhagat, N., Noordhoek, N., Radaelli, A., ... Geschwind, J.F. (2012). Comparing the detectability of hepatocellular carcinoma by C-arm dualphase cone-beam computed tomography during hepatic arteriography with conventional contrast-enhanced magnetic resonance imaging. CardioVascular and Interventional Radiology. 35(1):97-104. DOI: 10.1007/s00270-011-0118-x